Should Metabolic Imaging to Assess Minimal Residual Disease (MRD) Become a Clinical Endpoint in Multiple Myeloma?
2017/7/7
Journal of Clinical Oncology (JCO) Podcast
Frequently requested episodes will be transcribed first
Shownotes Transcript
No transcript made for this episode yet, you may request it for free.